FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Clontz Clarence Reid Jr. 2. Date of Event Requiring Statement (Month/Day/Year) 12/08/2025 3. Issuer Name and Ticker or Trading Symbol Ingevity Corp [NGVT] (Last) (First) (Middle) C/O INGEVITY CORPORATION 4920 O'HEAR AVE, SUITE 400 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP, Operations 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) NORTH CHARLESTON, SC 29405 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 7,029 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right-to-buy)	02/27/2020(1)	02/27/2027	Common Stock	217	$53.11	D
Employee Stock Option (right-to-buy)	02/28/2021(2)	02/28/2028	Common Stock	496	$74.91	D
Employee Stock Option (right-to-buy)	02/28/2022(3)	02/28/2029	Common Stock	351	$115.22	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Clontz Clarence Reid Jr. C/O INGEVITY CORPORATION 4920 O'HEAR AVE SUITE 400 NORTH CHARLESTON, SC 29405			SVP, Operations

Signatures

Clarence Reid Clontz, Jr. By: Mavis G. Huger as Attorney-in-Fact		12/18/2025
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 27, 2020.
(2)	These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 28, 2021.
(3)	These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested ratably in three equal installments. The first installment vested on February 28, 2020; the second installment vested on February 28, 2021; and the third installment vested on February 28, 2022.
Remarks: Exhibits: Exhibit 24 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.